These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15051270)

  • 1. Rofecoxib does not adversely affect skin graft survival in a rat model.
    Miller Q; Losken A; Harre JG; Bird ME
    Curr Surg; 2004; 61(2):227-30. PubMed ID: 15051270
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
    Umar A; Boisseau M; Yusup A; Upur H; Bégaud B; Moore N
    Fundam Clin Pharmacol; 2004 Oct; 18(5):559-63. PubMed ID: 15482377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy with rofecoxib. Decreasing risk by controlled COX-2 inhibitor administration].
    MMW Fortschr Med; 2000 Nov; 142(48):64-5. PubMed ID: 11144940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
    MMW Fortschr Med; 2003 Aug; 145(31-32):56-7. PubMed ID: 14524083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prof. Bernd Simon on nonsteroidal anti-inflammatory drugs. Gastrointestinal complications are unpredictable].
    Simon B
    MMW Fortschr Med; 2001 May; 143(18):51-2. PubMed ID: 11387712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Slime fight in the lay media. Were the Vioxx fatal cases kept secret?].
    Zierenberg O
    MMW Fortschr Med; 2004 Oct; 146(43):60. PubMed ID: 15559526
    [No Abstract]   [Full Text] [Related]  

  • 7. [80,000 patients with arthrosis treated. Coxib gets through a practice test, too].
    MMW Fortschr Med; 2002 Oct; 144(41):60. PubMed ID: 12474372
    [No Abstract]   [Full Text] [Related]  

  • 8. [Meta-analysis on acute pain. Rofecoxib helped three quarters of patients].
    MMW Fortschr Med; 2003 Aug; 145(31-32):57. PubMed ID: 14524084
    [No Abstract]   [Full Text] [Related]  

  • 9. The Vioxx debacle.
    Alpert JS
    Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
    Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
    Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gynecomastia secondary to rofecoxib].
    Martínez JA; Tejada González P; Gutiérrez Sanpedro N; González Blanco P
    Med Clin (Barc); 2002 Jun; 118(20):798-9. PubMed ID: 12049701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analgesic in osteoporosis. Why so conservative with dosage?].
    Pfeifer M
    MMW Fortschr Med; 2002 Sep; 144(35-36):9. PubMed ID: 12380349
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
    Nelson M; Cicuttini F
    Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of effects of rofecoxib on platelet function in an in vitro model of thrombosis with circulating human blood.
    Hernandez MR; Tonda R; Pino M; Serradell M; Arderiu G; Escolar G
    Eur J Clin Invest; 2004 Apr; 34(4):297-302. PubMed ID: 15086362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vioxx withdrawal alarms cancer prevention researchers.
    Vanchieri C
    J Natl Cancer Inst; 2004 Dec; 96(23):1734-5. PubMed ID: 15572751
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extreme sinus bradycardia (30/min) with acute right heart failure under tizanidine (Sirdalud). Possible pharmacological interaction with rofecoxib (Vioxx)].
    Kick A; Bertoli R; Moschovitis G; Caduff Janosa P; Cerny A
    Med Klin (Munich); 2005 Apr; 100(4):213-6. PubMed ID: 15834531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matters of the heart: assessing the cardiovascular safety of new drugs.
    Konstam MA
    Am Heart J; 2003 Oct; 146(4):561-2. PubMed ID: 14564304
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe cholestasis and acute renal failure related to rofecoxib.
    Linares P; Vivas S; Jorquera F; Olcoz JL; de Leon B; Oritz de Urbina J
    Am J Gastroenterol; 2004 Aug; 99(8):1622-3. PubMed ID: 15307886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Overestimated].
    Höer A; Häussler B
    Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.